首页 | 本学科首页   官方微博 | 高级检索  
     


Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short‐term prognosis
Authors:S. Schulman  M. Zondag  L. Linkins  S. Pasca  Y. W. Cheung  M. de Sancho  A. Gallus  R. Lecumberri  S. Molnar  W. Ageno  G. Le Gal  A. Falanga  E. Hulegårdh  S. Ranta  P. Kamphuisen  P. Debourdeau  V. Rigamonti  T. L. Ortel  A. Lee
Affiliation:1. Department of Medicine, McMaster University, Hamilton, ON, Canada;2. Karolinska Institutet, Stockholm, Sweden;3. Center for Hemorrhagic and Thrombotic Disease, University Hospital of Udine, Udine, Italy;4. Academic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands;5. Weill Cornell Medical College, New York, NY, USA;6. Flinders University, Adelaide, SA, Australia;7. Hematology Service, University Clinic of Navarra, Pamplona, Spain;8. Oncology and Hematology Department, Sanatorio Allende, Cordoba, Argentina;9. Department of Clinical and Experimental Medicine, University of Insubria, Varese, Italy;10. Department of Internal Medicine and Chest Diseases, Brest University Hospital, Brest, France;11. Department of Immunohematology and Transfusion Medicine, Hospital Papa Giovanni XXIII, Bergamo, Italy;12. Department of Hematology and Coagulation, Sahlgrenska University Hospital, Gothenburg, Sweden;13. Department of Vascular Medicine, University Medical Centre Groningen, University of Groningen, Groningen, the Netherlands;14. Oncology Department, Ste Catherine Institute, Avignon, France;15. Praxis Bubenberg, Bern, Switzerland;16. Division of Hematology, Duke University Medical Center, Durham, NC, USA;17. Diamond Health Care Centre, University of British Columbia and Vancouver Coastal Health, Vancouver, BC, Canada
Abstract:
Keywords:bleeding  cancer  low‐molecular‐weight heparin  venous thromboembolism  warfarin
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号